Evidence 1
Activity
Activity
IC50
IC50 =55.9 µM
Anticancer
55.9 µM
Target
Lung Cancer
HI-57
Lung
Assay & Model
MTT/MTS assay
24-h
Source & Reference
dbAMP 3.0
CancerPPD 2.0
dbACP
SATPdb
CancerPPD2
2013
Other
| Source Activity Label | Source Definition |
|---|---|
| Anticancer |
CancerPPD 2.0
manually curated experimentally verified anticancer peptide/protein annotation.
dbAMP 3.0
classified as Anticancer under the disease-associated peptide function classes.
|